| RS2143247486 |
SOX9
|
Health Risk |
Pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS2143247518 |
SOX9
|
Health Risk |
Pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS2143247529 |
SOX9
|
Health Risk |
Pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS2143250007 |
SOX9
|
Health Risk |
Pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS2143251066 |
SOX9
|
Health Risk |
Likely pathogenic |
SOX9-related disorder, SOX9-related disorder |
| RS2143251369 |
SOX9
|
Health Risk |
Likely pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS2143251627 |
SOX9
|
Health Risk |
Pathogenic |
CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL, CAMPOMELIC DYSPLASIA WITH AUTOSOMAL SEX REVERSAL |
| RS2143251700 |
WDR45B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2143254357 |
SOX9
|
Health Risk |
Pathogenic |
Camptomelic dysplasia, Camptomelic dysplasia |
| RS2143254539 |
SOX9
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2143255167 |
SMCHD1
|
Health Risk |
Pathogenic |
— |
| RS2143255337 |
SMCHD1
|
Health Risk |
Pathogenic |
Facioscapulohumeral muscular dystrophy 2, Facioscapulohumeral muscular dystrophy 2 |
| RS2143257416 |
SOX9
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS2143260759 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2143261385 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143268856 |
SPOP
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies, Neurodevelopmental disorder with relative macrocephaly and with or without cardiac or endocrine anomalies |
| RS2143269972 |
SPOP
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly and dysmorphic facies, Neurodevelopmental disorder with microcephaly and dysmorphic facies |
| RS2143272046 |
GNAO1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS2143272157 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143272162 |
GNAO1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 17 |
| RS2143272172 |
GNAO1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with involuntary movements, Neurodevelopmental disorder with involuntary movements |
| RS2143272260 |
GNAO1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2143272293 |
SPOP
|
Health Risk |
Likely pathogenic |
— |
| RS2143273650 |
SPOP
|
Health Risk |
Pathogenic/Likely pathogenic |
SPOP-related neurodevelopmental condition, SPOP-related neurodevelopmental condition |
| RS2143275431 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143275771 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143288193 |
MED13
|
Health Risk |
Likely pathogenic |
— |
| RS2143288270 |
MED13
|
Health Risk |
Pathogenic |
— |
| RS2143288542 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143288626 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143288874 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2143289454 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143289473 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Carney complex |
| RS2143293708 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143294238 |
PRKAR1A
|
Health Risk |
Pathogenic |
— |
| RS2143295744 |
SPOP
|
Health Risk |
Likely pathogenic |
SPOP-related disorder, Squamous cell carcinoma of the head and neck |
| RS2143300665 |
GATA6
|
Health Risk |
Pathogenic |
Atrioventricular septal defect 5, Atrioventricular septal defect 5 |
| RS2143300954 |
GATA6
|
Health Risk |
Pathogenic |
Atrioventricular septal defect 5, Atrioventricular septal defect 5 |
| RS2143307557 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143308216 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143312682 |
KIF1C
|
Health Risk |
Pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS2143313439 |
KIF1C
|
Health Risk |
Pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS2143317762 |
KIF1C
|
Health Risk |
Pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS2143317920 |
KIF1C
|
Health Risk |
Pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS2143321644 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney complex, type 1 |
| RS2143321666 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Arrhythmogenic right ventricular dysplasia 10, Arrhythmogenic right ventricular dysplasia 10 |
| RS2143322263 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143322920 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143323595 |
KIF1C
|
Health Risk |
Pathogenic |
Spastic ataxia 2, Spastic ataxia 2 |
| RS2143325096 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2143325486 |
GRN
|
Health Risk |
Pathogenic |
— |
| RS2143326580 |
GRN
|
Health Risk |
Likely pathogenic |
— |
| RS2143331597 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143331971 |
FANCA
|
Health Risk |
Likely pathogenic |
— |
| RS2143333169 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143335414 |
COG8
|
Health Risk |
Pathogenic |
COG8-congenital disorder of glycosylation, COG8-congenital disorder of glycosylation |
| RS2143335460 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS2143336220 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2143336354 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143336461 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143336491 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143337085 |
GRN
|
Health Risk |
Pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Melanoma |
| RS2143337849 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2143340252 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143340416 |
GRN
|
Health Risk |
Likely pathogenic |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS2143342203 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2143344327 |
GRN
|
Health Risk |
Pathogenic |
— |
| RS2143344360 |
GRN
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 11, GRN-related frontotemporal lobar degeneration with Tdp43 inclusions |
| RS2143345233 |
COG8
|
Health Risk |
Pathogenic |
— |
| RS2143347736 |
GRN
|
Health Risk |
Pathogenic |
— |
| RS2143348249 |
GRN
|
Health Risk |
Pathogenic |
— |
| RS2143349147 |
GRN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2143350378 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143351188 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143351554 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2143351760 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143366415 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2143366568 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2143367390 |
SMCHD1
|
Health Risk |
Pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS2143367693 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2143371167 |
P4HB
|
Health Risk |
Likely pathogenic |
Cole-Carpenter syndrome 1, Cole-Carpenter syndrome 1 |
| RS2143382149 |
KIF1C
|
Health Risk |
Pathogenic |
Abnormal central motor function, Abnormal central motor function |
| RS2143382661 |
PRKAR1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2143383024 |
RNF43
|
Health Risk |
Likely pathogenic |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS2143383396 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143383985 |
PRKAR1A
|
Health Risk |
Pathogenic |
Carney complex, type 1 |
| RS2143386698 |
MED13
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 61, Intellectual developmental disorder 61 |
| RS2143387678 |
MED13
|
Health Risk |
Likely pathogenic |
— |
| RS2143390883 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney complex, type 1 |
| RS2143391287 |
PRKAR1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Carney complex, type 1 |
| RS2143392408 |
PRKAR1A
|
Health Risk |
Likely pathogenic |
Carney complex, type 1 |
| RS2143393148 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2143393518 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2143405085 |
ZFHX3
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2143409098 |
RNF43
|
Health Risk |
Likely pathogenic |
Sessile serrated polyposis cancer syndrome, Neoplasm |
| RS2143410400 |
MED13
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder 61, Intellectual developmental disorder 61 |
| RS2143416425 |
JUP
|
Health Risk |
Pathogenic |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS2143417444 |
ITGA2B
|
Health Risk |
Likely pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia 1 |
| RS2143417979 |
TBX21
|
Health Risk |
Pathogenic |
Immunodeficiency 88, Immunodeficiency 88 |
| RS2143421042 |
PIEZO2
|
Health Risk |
Pathogenic |
Abnormality of the skeletal system, Abnormality of the skeletal system |